Magnesium Gluconicum G.L.

Magnesium gluconate, the active ingredient in Magnesium Gluconicum G.L., is a magnesium supplement presented as a solution for injection for intravenous use. It is employed to correct magnesium deficiency, treat hypomagnesemia, and address electrolyte imbalances in hospitalized patients, and is indicated for rapid restoration of serum magnesium levels under clinical supervision.

GNH USA supplies Magnesium Gluconicum G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, and pharmacies worldwide, ensuring quality and regulatory compliance across all markets.

Magnesium Gluconicum G.L. is used to manage conditions related to low magnesium levels and associated electrolyte disturbances. - Magnesium deficiency: restores serum magnesium concentrations and helps normalize neuromuscular function. - Hypomagnesemia: provides rapid intravenous replacement to correct acute deficits. - Electrolyte imbalance: contributes to overall electrolyte homeostasis when magnesium is a limiting factor.

Adverse reactions to Magnesium Gluconicum G.L. are generally related to the intravenous delivery of magnesium and may vary in frequency and severity.

Common Side Effects: - Injection site pain: mild discomfort or tenderness at the infusion site. - Flushing: transient redness or warmth sensation. - Nausea: occasional feeling of queasiness during or after infusion. - Hypotension: mild drop in blood pressure, especially with rapid administration.

Serious or Rare Side Effects: - Hypermagnesemia: excessive serum magnesium leading to cardiac arrhythmias or respiratory depression. - Severe allergic reaction: anaphylaxis presenting with rash, bronchospasm, or circulatory collapse. - Cardiac arrest: rare but possible with extreme hypermagnesemia. - Pulmonary edema: fluid accumulation in lungs due to rapid infusion volumes.

When using Magnesium Gluconicum G.L., clinicians should observe specific precautions to ensure patient safety and product integrity. - Assess baseline serum magnesium: measure levels before initiating therapy. - Adjust dose in renal impairment: reduce or monitor closely in patients with reduced kidney function. - Monitor cardiac function: observe ECG and blood pressure during infusion. - Avoid rapid bolus: administer over recommended time to prevent hypotension. - Review concomitant medications: consider drugs that also affect magnesium balance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium Gluconicum G.L. may interact with other medicines, altering their effectiveness or increasing toxicity.

Major Interactions (Avoid): - Calcium channel blockers: concurrent use can potentiate cardiovascular depression. - Neuromuscular blocking agents: magnesium can enhance their effects, risking prolonged paralysis.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: magnesium may reduce their nephrotoxic potential but requires monitoring. - Bisphosphonates: co‑administration can impair absorption; separate dosing times. - Digoxin: magnesium levels influence digoxin toxicity; monitor serum concentrations.